Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the …

BA Ference, HN Ginsberg, I Graham… - European heart …, 2017 - academic.oup.com
Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs)
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …

Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

BA Ference, I Graham, L Tokgozoglu… - Journal of the American …, 2018 - jacc.org
People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular
disease. Therefore, encouraging people to achieve ideal cardiovascular health represents …

Large-scale genome-wide association study of coronary artery disease in genetically diverse populations

C Tcheandjieu, X Zhu, AT Hilliard, SL Clarke… - Nature medicine, 2022 - nature.com
We report a genome-wide association study (GWAS) of coronary artery disease (CAD)
incorporating nearly a quarter of a million cases, in which existing studies are integrated with …

Genetics of blood lipids among~ 300,000 multi-ethnic participants of the Million Veteran Program

D Klarin, SM Damrauer, K Cho, YV Sun, TM Teslovich… - Nature …, 2018 - nature.com
Abstract The Million Veteran Program (MVP) was established in 2011 as a national research
initiative to determine how genetic variation influences the health of US military veterans …

Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease

BA Ference, JJP Kastelein, KK Ray, HN Ginsberg… - Jama, 2019 - jamanetwork.com
Importance Triglycerides and cholesterol are both carried in plasma by apolipoprotein B
(ApoB)–containing lipoprotein particles. It is unknown whether lowering plasma triglyceride …

[HTML][HTML] Interpreting findings from Mendelian randomization using the MR-Egger method

S Burgess, SG Thompson - European journal of epidemiology, 2017 - Springer
Abstract Mendelian randomization-Egger (MR-Egger) is an analysis method for Mendelian
randomization using summarized genetic data. MR-Egger consists of three parts:(1) a test …

[HTML][HTML] The MR-Base platform supports systematic causal inference across the human phenome

G Hemani, J Zheng, B Elsworth, KH Wade… - elife, 2018 - elifesciences.org
Results from genome-wide association studies (GWAS) can be used to infer causal
relationships between phenotypes, using a strategy known as 2-sample Mendelian …

[HTML][HTML] Causal associations between risk factors and common diseases inferred from GWAS summary data

Z Zhu, Z Zheng, F Zhang, Y Wu, M Trzaskowski… - Nature …, 2018 - nature.com
Health risk factors such as body mass index (BMI) and serum cholesterol are associated
with many common diseases. It often remains unclear whether the risk factors are cause or …

[HTML][HTML] A robust and efficient method for Mendelian randomization with hundreds of genetic variants

S Burgess, CN Foley, E Allara, JR Staley… - Nature …, 2020 - nature.com
Mendelian randomization (MR) is an epidemiological technique that uses genetic variants to
distinguish correlation from causation in observational data. The reliability of a MR …

A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization

J Bowden, F Del Greco M, C Minelli… - Statistics in …, 2017 - Wiley Online Library
Mendelian randomization (MR) uses genetic data to probe questions of causality in
epidemiological research, by invoking the Instrumental Variable (IV) assumptions. In recent …